Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Public-private funding to accelerate biopharmaceutical drug development

28.09.2007
New research funding announced today will help eliminate processing bottlenecks that are slowing the development and manufacture of new biopharmaceuticals.

The Bioprocessing Research Industry Club (BRIC), a public-private collaboration between two Research Councils and the UK biopharmaceutical community, has awarded £3.5 million to researchers at seven universities. The funding will bring new treatments a step closer by helping to develop faster and more efficient development and manufacturing techniques.

Biopharmaceuticals account for 30 per cent of drugs currently in development, and 10 per cent of the current market. Examples of current biopharmaceutical treatments include the use of therapeutic proteins to manage conditions associated with hormone deficiencies or cancers of breast, colon, prostate or pancreatic tissues. In the future, biopharmaceutical treatments may also be able to help with organ and tissue deficiencies or disease conditions associated with ageing. The projects funded by BRIC aim to improve the bioprocessing techniques and systems that underpin biopharmaceutical development and production.

This is the second round of funding awarded by BRIC - a funding collaboration between the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC) and the UK biopharmaceutical industry, with support from bioProcessUK. It has awarded funding to eight research teams at seven universities: the Universities of Birmingham, Imperial College London, Manchester, Newcastle, Nottingham, Sheffield and Strathclyde.

These projects build on the first round of BRIC funding which supported nine projects at ten universities with funds in excess of £5 million. The third and final call for BRIC will be announced in the next few weeks.

By combining funding from major public funders and industry, BRIC works to support the rapidly growing biological medicines industry in the UK, with the ultimate aim of accelerating therapy development for patients.

Dr John Birch, Chairman of the BRIC steering group and Chief Scientific Officer at Lonza Biologics, said: "Biological drug development offers tremendous promise for patients. The eight new projects funded by BRIC will make a significant contribution to the research underpinning bioprocessing and will help to provide both faster process development and more efficient manufacturing technology for new biopharmaceuticals."

Dr Doug Yarrow, BBSRC Director of Corporate Science said: "The UK has an outstanding research base in bioprocessing and the latest round of BRIC grants further promotes the UK's world-leading status. It is essential that research capabilities are translated into real benefits for patients. BRIC's funding enables this by strengthening the vital links between groundbreaking research in our universities and industry's needs."

Michelle Kilfoyle | alfa
Further information:
http://www.bbsrc.ac.uk

Further reports about: BRIC Development biopharmaceutical universities

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>